Royalty Report: Drugs, Pharmaceuticals, Therapeutic – Collection: 70184

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Drugs
  • Pharmaceuticals
  • Therapeutic
  • Disease

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 70184

License Grant
The Company and the Netherlands University have entered into a Patent License Agreement under we were granted a world-wide exclusive license pursuant to which we may have certain royalty obligations in relation to several central nervous system diseases.
Field of Use
This agreement pertains to the drug industry relating to the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders.

IPSCIO Record ID: 26348

License Grant
The Company entered into a 21 year exclusive worldwide license agreement with the University for the use, sale, offer to sell, make, export or import certain of the University's Peptide Patents.
License Property
The Company is developing potential therapeutic products based on stimulatory peptides of several key cytokines primarily for use in treating diseases and disorders of the peripheral and central nervous systems.
Field of Use
This agreement pertains to the biopharmaceutical industry.

IPSCIO Record ID: 3475

License Grant
The Licensee has entered into an exclusive License Agreement with an unnamed University.  The Licensee has obtained certain intellectual property from the University to commercialize, produce, manufacture, use and sell the patent rights.
Field of Use
The rights granted apply to the healthcare industry.  The Company is a development stage company in the process of developing a product to treat debilitating and fatal diseases of the central nervous system.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.